RK 006
Alternative Names: RK-006Latest Information Update: 11 Apr 2025
At a glance
- Originator RevolKa
- Class Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 28 Feb 2025 Early research in Unspecified in Japan (unspecified route), prior to February 2025 (Revolka pipeline, February 2025)